- This event has passed.
Bispecific Antibodies for the Management of Multiple Myeloma: Focus on Managing Toxicities
Click HERE to Access the Teams Link
Bispecific Antibodies for the Management of Multiple Myeloma: Focus on Managing Toxicities
Presented By: Ricardo D. Parrondo, MD
Assistant Professor of Medicine
Consultant, Department of Hematology-Oncology & Bone Marrow Transplantation and Cellular Therapies, Mayo Clinic
Ricardo D. Parrondo, M.D., is a senior associate consultant in the Division of Hematology/Oncology, Department of Internal Medicine at Mayo Clinic in Florida. Dr. Parrondo joined the staff of Mayo Clinic in 2018 and holds the academic rank of assistant professor of medicine, Mayo Clinic College of Medicine and Science.
Dr. Parrondo earned his B.A. at the University of Pennsylvania in Philadelphia and his M.D. at the American University of the Caribbean, Cupecoy, Netherlands Antilles. He completed his internal medicine residency at New Jersey Medical School, Rutgers University in Newark, New Jersey, and his hematology/oncology fellowship at Mayo Clinic School of Graduate Medical Education.
Dr. Parrondo has a strong interest in malignant hematology, hematopoietic stem cell transplantation, and cellular therapies, with a particular focus on plasma cell proliferative disorders. He conducts clinical and translational research to advance the treatment and outcomes of patients with plasma cell proliferative disorders. His work includes devising new strategies to improve the therapeutic outcomes of patients with multiple myeloma in addition to gaining a better understanding of the myeloma bone marrow microenvironment. He is also interested in improving the depth and duration of response in patients with multiple myeloma who undergo autologous stem cell transplant. He has authored numerous journal articles and abstracts and serves as a peer reviewer for Hematology/Oncology and Stem Cell Therapy.
Dr. Parrondo is a member of the American Society for Transplantation and Cellular Therapy, American Society of Clinical Oncology, American Society of Hematology,
